126
|
Khanna D, Allanore Y, Denton C, Matucci-Cerinic M, Pope J, Hinzmann B, Briody S, de Oliveira Pena J, Distler O. FRI0269 Diffuse Cutaneous Systemic Sclerosis (dcSSc) Referral and Diagnosis: Results of A Survey of Healthcare Providers. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
127
|
Wohlfahrt T, Weber S, Englbrecht M, Dees C, Beyer C, Distler O, Schett G, Distler J, Ramming A. SAT0021 Type 2 Innate Lymphoid Cells Are Rapidly and Persistently Recruited in Experimental Fibrosis and Their Counts Correlate with The Severity of Skin and Lung Fibrosis in Systemic Sclerosis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
128
|
Pachera E, Assassi S, Salazar G, Frank-Bertoncelj M, Dobrota R, Brock M, Kurreeman F, de Vries-Bouwstra J, Messemaker T, Feghali-Bostwick C, Distler J, Kania G, Distler O. FRI0247 The Involvement of The Long Noncoding H19x in tGFβ Signaling and Its Profibrotic Effects in Systemic Sclerosis and Other Fibrotic Diseases. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
129
|
Herrick A, Pan X, Peytrignet S, Hesselstrand R, Mouthon L, Brown E, Czirjak L, Distler J, Distler O, Fligelstone K, Gregory W, Ochiel R, Silman A, Vonk M, Lunt M, Denton C. FRI0261 Observational Study of Outcome in Patients with Early Diffuse Cutaneous Systemic Sclerosis Treated with Immunosuppressive Therapies (ESOS Study). Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2261] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
130
|
Khanna D, Allanore Y, Denton C, Matucci-Cerinic M, Pope J, Hinzmann B, Briody S, de Oliveira Pena J, Distler O. FRI0270 Patient Perception of Disease Burden in Diffuse Cutaneous Systemic Sclerosis (DcSSc). Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
131
|
Rudnik M, Stellato M, Blyszczuk P, Pachera E, Dobrota R, Maurer B, Klingel K, Henes J, Sotlar K, Distler O, Kania G. OP0289 Micrornas as Potential Regulators of Monocyte Differentiation and Function in Heart Fibrosis in Systemic Sclerosis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
132
|
Schulte-Pelkum J, Budde P, Zucht H, Wirtz D, Schulz-Knappe P, Distler O, Jordan S, Hunzelmann N, Schneider M, Maurer B. SAT0549 Validation of 3 Novel Autoantigens for Systemic Sclerosis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
133
|
Chakraborty D, Šumová B, Mallano T, Chen CW, Ramming A, Distler O, Schett G, Distler J. SAT0184 Signal Transducer and Activator of Transcription 3 (STAT3) Integrates Several Profibrotic Pathways in Systemic Sclerosis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
134
|
Renoux F, Stellato M, Pachera E, Impellizzieri D, Dees C, Distler J, Kania G, Boyman O, Distler O. OP0206 Fra2 Is Playing A Key Role in The Control of Treg Development and Autoimmunity. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.1823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
135
|
Lazzaroni M, Cavazzana I, Colombo E, Distler O, Dobrota R, Hernandez J, Hesselstrand R, Czirjak L, Varju C, Nagy G, Smith V, Caramaschi P, Riccieri V, Hachulla E, Romanowska-Prochnicka K, Balbir-Gurman A, Chatelus E, Araùjo A, Allanore Y, Airò P. OP0031 Risk Factors for Malignancies Synchronous To The Onset of Systemic Sclerosis in Patients Positive for Anti- RNA Polymerase III Antibodies: A Eustar Multicentre Study. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
136
|
Mattsson M, Boström C, Mihai C, Stöcker J, Geyh S, Stummvoll G, Gard G, Möller B, Hesselstrand R, Sandqvist G, Draghicescu O, Gherghe AM, Voicu M, Distler O, Smolen JS, Stamm TA. Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures. A multicentre European qualitative study and literature review. Eur J Phys Rehabil Med 2015; 51:405-421. [PMID: 25573599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND Systemic sclerosis (SSc) is an autoimmune disease where thickening of the skin can lead to reduced body function and limitations in activities. Severe forms can also affect and seriously damage inner organs. Patient-centred rehabilitation emphasises considerations of patients' background, experience and behavior which highlights the need to know if patient-reported outcome measures (PROMs) include such personal factors. AIM To identify and describe personal factors in the experiences of functioning and health of persons with SSc and to examine if and to what extent PROMs in SSc research cover these factors. DESIGN Data from a qualitative study with focus group interviews were analysed. PROMs in SSc research were identified in a literature review between 2008-2013. SETTING Participants were recruited from outpatient clinics at rheumatology department. POPULATION Sixty-three patients with SSc from four European countries participated. METHODS Data from interviews were analysed using a structure of personal factors developed by Geyh et al. Identified PROMs were analysed and linked to main concepts, related to the personal factors, found in the interview data. RESULTS Nineteen main concepts were related to the area "patterns of experience and behaviour" in the personal factor structure, 16 to "thoughts and beliefs", nine to "feelings", one to "motives" and one to "personal history and biography", respectively. Among the 35 PROMs identified, 15 did not cover any of the identified concepts. Concepts within the area "feelings" were mostly covered by the PROMs. Five of the PROMs covered "patterns of experience and behaviour", while "motives" and "personal history and biography" were not covered at all. Four of the identified PROMs covered concepts within the areas "feelings", "thoughts and beliefs" and "patterns of experience and behaviour" in the same instrument. The Illness Cognition Questionnaire and Illness Behaviour Questionnaire were such PROMs. CONCLUSION Patterns of experience and behaviour had the highest number of concepts related to personal factors, but few of the PROMs in SSc research covered these factors. Only a few PROMs covered several personal factors areas in the same instrument. CLINICAL REHABILITATION IMPACT The results would be of value when developing core sets for outcome measurements in SSc.
Collapse
|
137
|
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Czirjak L, Denton C, Fligelstone K, Welling J, Mueller-Ladner U. OP0061 Update of Eular Recommendations for the Treatment of Systemic Sclerosis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4695] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
138
|
Liang R, Dess C, Palumbo-Zerr K, Lin NY, Zhang Y, Distler O, Schett G, Distler J. AB0209 Gli-Inhibitors Simultaneously Target Canonical and Non-Canonical Hedgehog Pathways and Ameliorate the Pro-Fibrotic Effects of Transforming Growth Factor-β. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.5510] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
139
|
Dobrota R, Maurer B, Graf N, Mihai C, Kowal-Bielecka O, Allanore Y, Distler O. SAT0439 Prediction of Improvement in Skin Fibrosis in Diffuse Cutaneous Systemic Sclerosis – a Eustar Analysis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2129] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
140
|
Frerix M, Abignano G, Allanore Y, Avouac J, Czirják L, Del Galdo F, Denton C, Distler O, Foeldvari I, Garay Toth B, Guiducci S, Huscher D, Lόránd V, Jaeger V, Matucci-Cerinic M, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner I, Valentini G, Vettori S, Walker U, Müller-Ladner U. SAT0467 The Five Prospective Observational Trials of the International Systemic Sclerosis FP7-Health Research Project Desscipher: A Interim Report. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1441] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
141
|
Allanore Y, Jagerschmidt A, Jasson M, Distler O, Denton C, Khanna D. OP0266 Lysophophatidic Acid Receptor 1 Antagonist SAR100842 as a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2A Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3472] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
142
|
Huang J, Beyer C, Zerr K, Zhang Y, Ramming A, Distler A, Gelse K, Distler O, Schett G, Wollin S, Distler J. OP0211 Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2070] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
143
|
Radić M, Becker M, Distler O, Huscher D, Riemekasten G. SAT0434 Does Angiotensin and Endothelin Receptor Blockade Have an Impact on Lung Function? an Analysis from the Eustar Data Base. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.6092] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
144
|
Lepri G, Avouac J, Airò P, Anguita Santos F, Bellando Randone S, Blagojevic J, Distler O, Garcìa Hernàndez F, Gonzalez Nieto J, Guiducci S, Jordan S, Limaye V, Maurer B, Riccieri V, Selva-O'Calaghan A, Matucci Cerinic M, Allanore Y. AB0698 MID-Term Effects of Rituximab in Connective Tissue Disorders Related Interstitial Lung Disease (ILD). Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.6310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
145
|
Maurer B, Moritz F, Distler J, Michel B, Gay R, Gay S, Distler O. FRI0434 TIE2 As a Novel Key Factor of Microangiopathy in Systemic Sclerosis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
146
|
Frantz C, Avouac J, Distler O, Amrouche F, Godard D, Kennedy A, Varga J, Matucci M, Allanore Y. OP0060 Impaired Quality of Life in Systemic Sclerosis and Patient Perception of the Disease: A Large International Survey. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
147
|
Lazzaroni M, Colombo E, Cavazzana I, Distler O, Hesselstrand R, Smith V, Caramaschi P, Hachulla E, Balbir-Gurman A, Romanowska-Pròchnicka K, Riccieri V, Allanore Y, Airo' P. OP0055 Anti-RNA Polymerase III Antibodies in Patients with Systemic Sclerosis: A Eustar Multicenter Collaborative Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
148
|
Toniolo M, Dobrota R, Moinzadeh P, Ogawa R, Furst D, Denton C, Khanna D, Distler O. AB0724 Biomarkers Sensitive to Change in Patients with Systemic Sclerosis – a Systematic Review. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.5282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
149
|
Saketkoo L, Escorpizo R, Keen K, Fligelstone K, Birring S, Lammi M, Lasky J, LeSage D, Renzoni E, Russell A, Sarver C, Scholand M, Varga J, Distler O. FRI0474 International Classification of Functioning, Disability, and Health (ICF) Core Sets for Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) and Idiopathic Pulmonary Fibrosis (IPF) – A Necessary Map to Health Care Provision in the ERA of ICD-11. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
150
|
Vettori S, Cuomo G, Jaeger V, Frerix M, Siegert E, Lorand V, Jordan S, Riemekasten G, Allanore Y, Czirjak L, Tarner I, Distler O, Denton C, Matucci-Cerinic M, Del Galdo F, Walker U, Mueller-Ladner U, Valentini G. FRI0446 Severe Heart Disease in Systemic Sclerosis: Prevalence, Risk Factors and Current Treatment. A Eustar-Desscipher Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|